questionsmedicales.fr
Maladies de l'appareil respiratoire
Tumeurs de l'appareil respiratoire
Tumeurs du poumon
Tumeurs des bronches
Carcinome bronchogénique
Carcinome bronchogénique : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Carcinome bronchogénique
Biopsie
Tomodensitométrie
Radiographie
Bronchoscopie
Tomodensitométrie
Marqueurs tumoraux
Carcinome bronchogénique
Suivi
Imagerie médicale
Carcinome bronchogénique
Évaluation
Scanner thoracique
Symptômes respiratoires
Carcinome bronchogénique
Symptômes
5
Toux
Essoufflement
Hémoptysie
Douleur thoracique
Carcinome bronchogénique
Respiration
Fatigue
Perte de poids
Fièvre
Consultation médicale
Toux persistante
Difficultés respiratoires
Types histologiques
Carcinome bronchogénique
Symptômes
Prévention
5
Prévention
Tabagisme
Agents cancérigènes
Dépistage
Scanner
Fumeurs
Arrêt du tabac
Substituts nicotiniques
Groupes de soutien
Alimentation
Fruits et légumes
Carcinome bronchogénique
Expositions professionnelles
Amiante
Carcinome bronchogénique
Traitements
5
Chirurgie
Chimiothérapie
Radiothérapie
Chirurgie
Tumeurs localisées
Carcinome bronchogénique
Chimiothérapie
Effets secondaires
Infections
Radiothérapie palliative
Soulagement de la douleur
Carcinome bronchogénique
Thérapies ciblées
Mutations
Carcinome bronchogénique
Complications
5
Complications
Métastases
Pneumonie
Métastases
Symptômes
Carcinome bronchogénique
Obstruction bronchique
Difficultés respiratoires
Carcinome bronchogénique
Infections pulmonaires
Pneumonie
Carcinome bronchogénique
Gestion des complications
Suivi médical
Traitements
Facteurs de risque
5
Facteurs de risque
Tabagisme
Pollution de l'air
Âge
Risque
Carcinome bronchogénique
Antécédents familiaux
Risque
Carcinome bronchogénique
BPCO
Maladies pulmonaires
Carcinome bronchogénique
Produits chimiques
Risque
Carcinome bronchogénique
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Carcinome bronchogénique : Questions médicales les plus fréquentes",
"headline": "Carcinome bronchogénique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Carcinome bronchogénique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-01",
"dateModified": "2025-12-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Carcinome bronchogénique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Tumeurs des bronches",
"url": "https://questionsmedicales.fr/mesh/D001984",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs des bronches",
"code": {
"@type": "MedicalCode",
"code": "D001984",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C08.785.520.100"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Carcinome pulmonaire non à petites cellules",
"alternateName": "Carcinoma, Non-Small-Cell Lung",
"url": "https://questionsmedicales.fr/mesh/D002289",
"about": {
"@type": "MedicalCondition",
"name": "Carcinome pulmonaire non à petites cellules",
"code": {
"@type": "MedicalCode",
"code": "D002289",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C08.785.520.100.220.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Carcinome pulmonaire à petites cellules",
"alternateName": "Small Cell Lung Carcinoma",
"url": "https://questionsmedicales.fr/mesh/D055752",
"about": {
"@type": "MedicalCondition",
"name": "Carcinome pulmonaire à petites cellules",
"code": {
"@type": "MedicalCode",
"code": "D055752",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C08.785.520.100.220.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Carcinome bronchogénique",
"alternateName": "Carcinoma, Bronchogenic",
"code": {
"@type": "MedicalCode",
"code": "D002283",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Ravikanth Reddy",
"url": "https://questionsmedicales.fr/author/Ravikanth%20Reddy",
"affiliation": {
"@type": "Organization",
"name": "Department of Radiology, St. John's Hospital, Bengaluru 560034, Karnataka, India. ravikanthreddy06@gmail.com."
}
},
{
"@type": "Person",
"name": "Chika Miyasaka",
"url": "https://questionsmedicales.fr/author/Chika%20Miyasaka",
"affiliation": {
"@type": "Organization",
"name": "The Department of Pathology, Kansai Medical University."
}
},
{
"@type": "Person",
"name": "Koji Tsuta",
"url": "https://questionsmedicales.fr/author/Koji%20Tsuta",
"affiliation": {
"@type": "Organization",
"name": "The Department of Pathology, Kansai Medical University."
}
},
{
"@type": "Person",
"name": "Paul Zarogoulidis",
"url": "https://questionsmedicales.fr/author/Paul%20Zarogoulidis",
"affiliation": {
"@type": "Organization",
"name": "3rd University General Hospital, ''AHEPA'' University Hospital, Thessaloniki, Greece."
}
},
{
"@type": "Person",
"name": "Kosmas Tsakiridis",
"url": "https://questionsmedicales.fr/author/Kosmas%20Tsakiridis",
"affiliation": {
"@type": "Organization",
"name": "Thoracic Surgery Department, ''Interbalkan'' European Medical Center, Thessaloniki, Greece."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A prospective comparative study of [",
"datePublished": "2023-02-22",
"url": "https://questionsmedicales.fr/article/36811661",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00259-023-06142-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Nutrients and Dementia: Prospective Study.",
"datePublished": "2023-02-07",
"url": "https://questionsmedicales.fr/article/36839199",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/nu15040842"
}
},
{
"@type": "ScholarlyArticle",
"name": "A prospective study to compare the diagnostic accuracy of",
"datePublished": "2024-09-26",
"url": "https://questionsmedicales.fr/article/39327339",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00432-024-05953-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clinical prospective study of Gallium 68 (",
"datePublished": "2023-02-21",
"url": "https://questionsmedicales.fr/article/36809426",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00259-023-06137-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "The INTOXICATE study: methodology and preliminary results of a prospective observational study.",
"datePublished": "2024-09-27",
"url": "https://questionsmedicales.fr/article/39334221",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13054-024-05096-7"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies de l'appareil respiratoire",
"item": "https://questionsmedicales.fr/mesh/D012140"
},
{
"@type": "ListItem",
"position": 3,
"name": "Tumeurs de l'appareil respiratoire",
"item": "https://questionsmedicales.fr/mesh/D012142"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tumeurs du poumon",
"item": "https://questionsmedicales.fr/mesh/D008175"
},
{
"@type": "ListItem",
"position": 5,
"name": "Tumeurs des bronches",
"item": "https://questionsmedicales.fr/mesh/D001984"
},
{
"@type": "ListItem",
"position": 6,
"name": "Carcinome bronchogénique",
"item": "https://questionsmedicales.fr/mesh/D002283"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Carcinome bronchogénique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Carcinome bronchogénique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-02-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Carcinome bronchogénique",
"description": "Comment diagnostiquer un carcinome bronchogénique ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels marqueurs tumoraux sont associés ?\nQuelle est l'importance de l'imagerie ?\nQuand faire un scanner thoracique ?",
"url": "https://questionsmedicales.fr/mesh/D002283?mesh_terms=Prospective+Studies#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Carcinome bronchogénique",
"description": "Quels sont les symptômes courants ?\nComment la douleur thoracique se manifeste-t-elle ?\nY a-t-il des symptômes systémiques ?\nQuand consulter un médecin pour des symptômes ?\nLes symptômes varient-ils selon le type de carcinome ?",
"url": "https://questionsmedicales.fr/mesh/D002283?mesh_terms=Prospective+Studies#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Carcinome bronchogénique",
"description": "Comment prévenir le carcinome bronchogénique ?\nLe dépistage est-il utile ?\nQuels sont les conseils pour arrêter de fumer ?\nL'alimentation joue-t-elle un rôle ?\nLes expositions professionnelles sont-elles un risque ?",
"url": "https://questionsmedicales.fr/mesh/D002283?mesh_terms=Prospective+Studies#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Carcinome bronchogénique",
"description": "Quels traitements sont disponibles ?\nQuand la chirurgie est-elle recommandée ?\nQuels sont les effets secondaires de la chimiothérapie ?\nQu'est-ce que la radiothérapie palliative ?\nLes thérapies ciblées sont-elles efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D002283?mesh_terms=Prospective+Studies#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Carcinome bronchogénique",
"description": "Quelles complications peuvent survenir ?\nComment les métastases affectent-elles le corps ?\nQu'est-ce qu'une obstruction bronchique ?\nLes infections pulmonaires sont-elles fréquentes ?\nComment gérer les complications ?",
"url": "https://questionsmedicales.fr/mesh/D002283?mesh_terms=Prospective+Studies#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Carcinome bronchogénique",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nLes maladies pulmonaires chroniques sont-elles un facteur ?\nL'exposition à des produits chimiques est-elle risquée ?",
"url": "https://questionsmedicales.fr/mesh/D002283?mesh_terms=Prospective+Studies#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un carcinome bronchogénique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par imagerie (radiographie, scanner) et biopsie."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent la radiographie thoracique, la tomodensitométrie et la bronchoscopie."
}
},
{
"@type": "Question",
"name": "Quels marqueurs tumoraux sont associés ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les marqueurs comme le CEA et le CYFRA 21-1 peuvent être utilisés pour le suivi."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'imagerie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie permet de visualiser les tumeurs et d'évaluer leur taille et leur localisation."
}
},
{
"@type": "Question",
"name": "Quand faire un scanner thoracique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un scanner est recommandé si des symptômes respiratoires persistent ou s'aggravent."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent toux persistante, essoufflement, douleur thoracique et hémoptysie."
}
},
{
"@type": "Question",
"name": "Comment la douleur thoracique se manifeste-t-elle ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "La douleur thoracique peut être aiguë ou sourde, souvent aggravée par la respiration."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes systémiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, fatigue, perte de poids et fièvre peuvent également être présents."
}
},
{
"@type": "Question",
"name": "Quand consulter un médecin pour des symptômes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez si vous avez une toux persistante ou des difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de carcinome ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon le type histologique du carcinome bronchogénique."
}
},
{
"@type": "Question",
"name": "Comment prévenir le carcinome bronchogénique ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabagisme et l'exposition à des agents cancérigènes réduit le risque."
}
},
{
"@type": "Question",
"name": "Le dépistage est-il utile ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage par scanner est recommandé pour les fumeurs à risque élevé."
}
},
{
"@type": "Question",
"name": "Quels sont les conseils pour arrêter de fumer ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez un professionnel, utilisez des substituts nicotiniques et rejoignez des groupes de soutien."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en fruits et légumes peut réduire le risque de cancer du poumon."
}
},
{
"@type": "Question",
"name": "Les expositions professionnelles sont-elles un risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à l'amiante et à d'autres substances toxiques augmente le risque."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent chirurgie, chimiothérapie, radiothérapie et thérapies ciblées."
}
},
{
"@type": "Question",
"name": "Quand la chirurgie est-elle recommandée ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est recommandée pour les tumeurs localisées et opérables."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires de la chimiothérapie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent nausées, fatigue, perte de cheveux et infections."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que la radiothérapie palliative ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La radiothérapie palliative soulage la douleur et d'autres symptômes sans guérir le cancer."
}
},
{
"@type": "Question",
"name": "Les thérapies ciblées sont-elles efficaces ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont efficaces pour certains types de carcinome bronchogénique avec mutations spécifiques."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent métastases, pneumonie et obstruction des voies respiratoires."
}
},
{
"@type": "Question",
"name": "Comment les métastases affectent-elles le corps ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les métastases peuvent toucher d'autres organes, entraînant des symptômes variés selon la localisation."
}
},
{
"@type": "Question",
"name": "Qu'est-ce qu'une obstruction bronchique ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obstruction bronchique se produit lorsque la tumeur bloque les voies respiratoires, causant des difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "Les infections pulmonaires sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections pulmonaires comme la pneumonie sont fréquentes chez les patients atteints."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite un suivi médical régulier et des traitements adaptés."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme, l'exposition à l'amiante et la pollution de l'air sont des facteurs de risque majeurs."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge, surtout après 55 ans."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de cancer du poumon augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les maladies pulmonaires chroniques sont-elles un facteur ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme la BPCO augmentent le risque de développer un carcinome bronchogénique."
}
},
{
"@type": "Question",
"name": "L'exposition à des produits chimiques est-elle risquée ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des produits chimiques comme le benzène et le formaldéhyde est un risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 21/12/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Department of Radiology, St. John's Hospital, Bengaluru 560034, Karnataka, India. ravikanthreddy06@gmail.com.
Publications dans "Carcinome bronchogénique" :
2 publications dans cette catégorie
Affiliations :
The Department of Pathology, Kansai Medical University.
Publications dans "Carcinome bronchogénique" :
2 publications dans cette catégorie
Affiliations :
The Department of Pathology, Kansai Medical University.
Publications dans "Carcinome bronchogénique" :
2 publications dans cette catégorie
Affiliations :
3rd University General Hospital, ''AHEPA'' University Hospital, Thessaloniki, Greece.
Publications dans "Carcinome bronchogénique" :
2 publications dans cette catégorie
Affiliations :
Thoracic Surgery Department, ''Interbalkan'' European Medical Center, Thessaloniki, Greece.
Publications dans "Carcinome bronchogénique" :
2 publications dans cette catégorie
Affiliations :
Pulmonary Department (NHS), ''G. Papanikolaou'' General Hospital, Thessaloniki, Greece.
Publications dans "Carcinome bronchogénique" :
2 publications dans cette catégorie
Affiliations :
Pulmonary Department (NHS), ''G. Papanikolaou'' General Hospital, Thessaloniki, Greece.
Publications dans "Carcinome bronchogénique" :
1 publication dans cette catégorie
Affiliations :
Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Publications dans "Carcinome bronchogénique" :
1 publication dans cette catégorie
Affiliations :
Fullerton Healthcare Corporate Limited, Singapore.
Publications dans "Carcinome bronchogénique" :
1 publication dans cette catégorie
Affiliations :
Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Publications dans "Carcinome bronchogénique" :
1 publication dans cette catégorie
Affiliations :
Jane Yap Chest & Medical Clinic Pte Ltd, Mount Alvernia Specialist Centre, Singapore.
Publications dans "Carcinome bronchogénique" :
1 publication dans cette catégorie
Affiliations :
Department of Surgery, Al Jamhori Teaching Hospital, Mousl 41001, Republic of Iraq.
Publications dans "Carcinome bronchogénique" :
1 publication dans cette catégorie
Affiliations :
Department of Surgery, Medical City, Baghdad 10011, Republic of Iraq.
Publications dans "Carcinome bronchogénique" :
1 publication dans cette catégorie
Affiliations :
Department of Surgery, Mousl Cardiac Center, Mousl 41001, Republic of Iraq.
Publications dans "Carcinome bronchogénique" :
1 publication dans cette catégorie
Affiliations :
Kscien Organization for Scientific Research, University of Sulaimani, Sulaimani 46000, Republic of Iraq.
Smart Health Tower, University of Sulaimani, Sulaimani 46000, Republic of Iraq.
College of Medicine, University of Sulaimani, Sulaimani 46000, Republic of Iraq.
Publications dans "Carcinome bronchogénique" :
1 publication dans cette catégorie
Affiliations :
Smart Health Tower, University of Sulaimani, Sulaimani 46000, Republic of Iraq.
Publications dans "Carcinome bronchogénique" :
1 publication dans cette catégorie
Affiliations :
Smart Health Tower, University of Sulaimani, Sulaimani 46000, Republic of Iraq.
College of Medicine, University of Sulaimani, Sulaimani 46000, Republic of Iraq.
Publications dans "Carcinome bronchogénique" :
1 publication dans cette catégorie
Affiliations :
Kscien Organization for Scientific Research, University of Sulaimani, Sulaimani 46000, Republic of Iraq.
Smart Health Tower, University of Sulaimani, Sulaimani 46000, Republic of Iraq.
College of Medicine, University of Sulaimani, Sulaimani 46000, Republic of Iraq.
Publications dans "Carcinome bronchogénique" :
1 publication dans cette catégorie
Affiliations :
Department of Oncology, Hiwa Cancer Hospital, Sulaimani 46000, Republic of Iraq.
Publications dans "Carcinome bronchogénique" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiothoracic and Vascular Surgery, Shar Hospital, Sulaimani 46000, Republic of Iraq.
Publications dans "Carcinome bronchogénique" :
Prostate-specific membrane antigen (PSMA)-based PET/CT imaging has limitations in the diagnosis of prostate cancer (PCa). We recruited 207 participants with suspicious PCa to perform PET/CT imaging wi...
Every participant with suspicious PCa was scanned with both [...
Of the 207 participants analyzed, 125 had cancer, and 82 were diagnosed with benign prostatic hyperplasia (BPH). The sensitivity and specificity of [...
This prospective study provided evidence for the superior accuracy of [...
The association of diet and nutrients with dementia risk is an interesting research topic. Middle-aged and older Europeans not diagnosed with dementia within two years of baseline were followed up and...
To explore the value of...
This research was approved by the hospital ethics review committee. Sixty-three patients with NSCLC received...
For all patients and surgical patients, the accuracies of...
This preliminary clinical study shows that...
This study is to investigate the [...
A prospective study (NCT05264688) was performed between January 2022 and July 2022. Fifty participants were scanned using [...
In total, 47 participants (mean age 59.09 ± 10.98 [range 33-80 years]) were evaluated. The [...
[...
clinicaltrials.gov: NCT 05,264,688....
There is currently no practice-based, multicenter database of poisoned patients admitted to intensive care units (ICUs). The INTOXICATE study, endorsed by the ESICM and EAPCCT, aimed to determine the ...
Ethical approval was obtained for this multicenter, prospective observational study, and data-sharing agreements were signed with each participating center. An electronic case report form was used to ...
Seventy-eight ICUs, mainly from Europe, but also from Australia and the Eastern Mediterranean, participated. A total of 2,273 patients were enrolled between November 2020 and June 2023. The median age...
The vast majority of patients survive, and approximately one third of patients do not receive any ICU-specific interventions after admission in an intensive care unit for acute intoxication. High-qual...
OSF registration ID: osf.io/7e5uy....
Principles of safe cholecystectomy include dissection of the hepatocystic triangle and identification of the bilio-vascular structures to achieve critical view of safety. The aim of the present study ...
All consecutive patients who underwent laparoscopic cholecystectomy were included in the study. Recommended techniques of safe cholecystectomy were followed. Rouviere's sulcus was classified into four...
Five hundred patients were included in the study. Critical view of safety was achieved in 463 (92.6%) patients. Type1 Rouviere's sulcus was the most common variant found in 263 (52.6%). Normal cystic ...
Wide variation in the anatomical structures is noted when principles of safe laparoscopic cholecystectomy is followed. Awareness is paramount to avoid bilio-vascular injury during surgery....
There are limited studies on the use of bronchodilators for the treatment of bronchiectasis. This study investigated the efficacy of tiotropium in patients with bronchiectasis and airflow limitation....
This study was a prospective cohort study, including 169 patients with bronchiectasis and airflow limitation from 2015 to 2019. The clinical outcomes observed in our study were the effect of tiotropiu...
After 12 months, the annual decline in the FEV...
In conclusion, prospective cohort study showed that tiotropium effectively ameliorated the annual decline in the FEV...
Clozapine-induced myocarditis and cardiomyopathy are difficult to detect clinically and may be fatal if not detected early. The current/routine biomarkers for clozapine-induced myocarditis are non-spe...
The Clozapine Safety Study was a prospective, longitudinal, observational study to determine what, if any, the plasma concentrations of clozapine, N-desmethylclozapine, and clozapine-N-oxide in patien...
Sixty-seven patients were included. Six patients were diagnosed with myocarditis; none were diagnosed with cardiomyopathy in the study period. In patients not undergoing dose titration, clozapine biot...
The assessment of clozapine-N-oxide formation, and N-oxidation relative to N-desmethylation ratios during treatment, may help identify a biomarker to aid the early detection of patients at risk of dev...
The different phases of a woman's life, such as the reproductive phase and menopause, are points of great hormonal oscillation, especially estrogen and progesterone, which can interfere with skin temp...
To describe and compare skin temperatures of women during their physiological menstrual cycle, the use of exogenous hormones and menopause over a period of 28 days....
This is a prospective observational study using a quantitative approach. A total of 45 volunteers participated and were equally allocated into three groups: Exogenous Hormone Group (EHG), Physiologica...
No significant differences were found between the mean skin temperature of women with a physiological cycle using exogenous hormones and menopause in relation to the evaluation time or between groups....
It was observed that the general skin temperature of women is not altered due to exogenous hormones, menstrual cycle phase or menopause, and that skin temperature tends to be lower in regions with an ...
Historically, norepinephrine has been administered through a central venous catheter (CVC) because of concerns about the risk of ischemic tissue injury if extravasation from a peripheral IV catheter (...
Can a protocol for peripheral norepinephrine administration safely reduce the number of days a CVC is in use and frequency of CVC placement?...
This was a prospective observational cohort study conducted in the medical ICU at a quaternary care academic medical center. A protocol for peripheral norepinephrine administration was developed and i...
The primary outcome was the number of days of CVC use that were avoided per patient, and the secondary safety outcomes included the incidence of extravasation events. Six hundred thirty-five patients ...
This study suggests that implementing a protocol for peripheral administration of norepinephrine safely can avoid 1 CVC day in the average patient, with 51.6% of patients not requiring CVC insertion. ...